PRESS RELEASE published on 01/20/2026 at 18:30, 6 months 19 days ago Informations privilégiées / Autres communiqués MaaT Pharma annonce la randomisation du premier patient dans IMMUNOLIFE, essai Phase 2 promu par Gustave Roussy évaluant le rôle du microbiote pour contourner la résistance aux ICI chez des patients CPNPC avancé avec dysbiose liée aux antibiotiques Essai Clinique Microbiote MaaT Pharma Cancer Du Poumon IMMUNOLIFE
PRESS RELEASE published on 01/20/2026 at 18:30, 6 months 19 days ago Inside Information / Other news releases MaaT Pharma announces first patient randomized in IMMUNOLIFE Phase 2 study sponsored by Gustave Roussy to explore the role of gut microbiome in overcoming ICI resistance in NSCLC patients with antibiotic-induced dysbiosis NSCLC MaaT Pharma Gut Microbiome Antibiotic-induced Dysbiosis IMMUNOLIFE
BRIEF published on 12/10/2025 at 11:30, 7 months 30 days ago MaaT Pharma SACA Maintains Positive Outlook as Phase 3 Trial Data Strengthens Buy Recommendation Phase 3 Trial MaaT Pharma Xervyteg GI-aGvHD
BRIEF published on 12/10/2025 at 11:30, 7 months 30 days ago MaaT Pharma SACA maintient des perspectives positives alors que les données de l'essai de phase 3 se renforcent. Recommandation D'achat Essai De Phase 3 MaaT Pharma Xervyteg GI-aGvHD
PRESS RELEASE published on 12/10/2025 at 11:25, 7 months 30 days ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates recommendation to BUY for MaaT Pharma SACA with a target price of €17 following positive phase 3 trial results for Xervyteg presented at ASH Annual Meeting 2025 First Berlin Equity Research Buy Recommendation ASH Annual Meeting Xervyteg MaaT Pharma SACA
BRIEF published on 11/21/2025 at 11:27, 8 months 18 days ago Franchissement de Seuils chez MAAT PHARMA Droits De Vote Augmentation De Capital Franchissement De Seuils MaaT Pharma Invus Public Equities
BRIEF published on 11/21/2025 at 11:27, 8 months 18 days ago Crossing Thresholds at MAAT PHARMA Voting Rights Capital Increase Crossing Thresholds MaaT Pharma Invus Public Equities
PRESS RELEASE published on 11/21/2025 at 11:22, 8 months 18 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities1, L.P. concernant MAAT PHARMA sur Euronext Paris. Augmentation de capital. Détention de 6,24% du capital et des droits de vote Euronext Paris Augmentation De Capital Franchissement De Seuils MaaT Pharma 6,24%
BRIEF published on 11/19/2025 at 11:16, 8 months 20 days ago MaaT Pharma Secures Capital to Support Commercialization Efforts Capital Increase MaaT Pharma Biotech Investment Xervyteg AGvHD Treatment
BRIEF published on 11/19/2025 at 11:16, 8 months 20 days ago MaaT Pharma obtient des capitaux pour soutenir ses efforts de commercialisation Augmentation De Capital MaaT Pharma Investissement En Biotechnologie Xervyteg Traitement De La GVHD Aiguë
Published on 08/07/2026 at 23:15, 1 day 16 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 16 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 17 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 17 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/09/2026 at 15:05, 26 minutes ago GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/09/2026 at 00:01, 15 hours 30 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 23 hours 6 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 16 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 20 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 18:54, 1 day 20 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 20 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 20 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 20 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 21 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
